FDA Approved: JESDUVROQ — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved JESDUVROQ (daprodustat) from GlaxoSmithKline in an original application for the treatment of anemia due to chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• JESDUVROQ (DAPRODUSTAT)

Snippet

ORIG AP for JESDUVROQ (DAPRODUSTAT)